Sign in
CompletedPhase 4

Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome

Key facts

Who runs it
EP Plus Group Sdn Bhd
Where
Malaysia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
57 people enrolled
Started
17 Oct 2024
Ended
14 Apr 2026
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Skal Pro
  • Placebo
Record updated
11 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • IBS diagnosed using the Rome IV criteria
  • Age above 18 years old and any gender
  • Any subtypes of IBS (diarrhea, constipation or mixed)

Who cannot take part

  • Previous abdominal surgeries
  • Was previously prescribed probiotic Skal Pro™ (LP299V™)
  • Presence of red flag symptoms (weight loss, anemia, night symptoms, abdominal mass, strong family history of cancer)
  • Medical conditions that contraindicate probiotic use including severe sepsis and pregnancy
  • Presence of bowel malignancy
  • Diagnosis of bowel infection within the past one month
  • Patients with overt psychiatric illnesses including schizophrenia and manic disorders
  • A history of allergy to probiotic
  • Was prescribed antibiotic (s) within the past one month
  • Was prescribed probiotic (s) within the past one month

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The objective of this randomized, double-blind, placebo-controlled study is to evaluate the effectiveness of Skal Pro in alleviating symptoms, enhancing stool consistency, improving quality of life, and addressing psychological distress in individuals diagnosed with irritable bowel syndrome (IBS), as compared to those who receive no intervention.

The 2 groups in the trial

  • Skal ProTreatment being tested

    Skal Pro in the form of 2g sachet powder contains 10 billion CFU of freeze-dried Lactobacillus plantarum 299v (LP299V) and galactooligosaccharides (GOS).

  • PlaceboPlacebo, for comparison

    Placebo is an oral formulation of inert powder. Placebo and Skal Pro are identical in shape, size, colour, packaging and taste.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized Double-Blind Placebo-controlled Clinical Trial on the Efficacy of Skål Pro (Lactobacillus Plantarum 299 and Galacto-oligosaccharides) in Improving Severity of Symptoms, Stool Forms, Quality of Life and Psychological Dysfunction in Patients With Irritable Bowel Syndrome (IBS)
Record updated
11 September 2026